Celanese Corporation's stock has decreased by 14% to $58.40 after the company reported first-quarter revenues of $2.34 billion, which fell short of earnings estimates by 55% with an EPS of $0.40. Despite a 2.2% year-over-year decline in revenue, analysts are optimistic, raising the 2026 revenue forecast to $9.92 billion as Celanese targets growth in high-value sectors like medical and electronics. In response to ongoing challenges, the company is focusing on cash generation and expects to save around $30 million through operational adjustments.
“Celanese Corporation · has stock price · US$58.40 · 14% decrease”
“Celanese Corporation · reported revenues · US$2.3b · in line with analyst predictions”
“Celanese Corporation · reported statutory earnings · US$0.40 per share · missed estimates by 55%”
“Celanese Corporation · 2026 revenue consensus forecast · US$9.92b · 4.6% improvement”
“Celanese Corporation · 2026 statutory earnings forecast · US$5.45 per share · increase in estimates”
“Celanese Corporation · analysts' price target · US$74.13 · 6.1% increase”
“Celanese Corporation · is prioritizing · cash generation and flexibility · as weak end-market demand continues”
“Celanese · is offsetting · higher feedstock costs · with pricing actions”
“Celanese · is targeting · growth in higher-value areas · such as medical, electronics, data centers and industrial applications”
“Celanese · expects · about $30 million of savings · from announced actions in the U.S. and Singapore”
“Celanese Corporation · is a · global chemical and specialty materials company”
“Celanese · distributed · first quarter earnings release · via Business Wire”
